ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Hollings Cancer Center at MUSC Wins NCI Designation

March 6, 2009

AACR President: Cancer Program ‘Threatened,’ Calls For Strategic Plan, More Extramural Input

December 6, 1991

ACS Research Budget Over $82 Million

July 17, 1987

NS Offers Research Grants, Scholarships

September 22, 1989

Breast Cancer Researchers Plan Collaborative Studies

February 27, 2004

DeVita Appointment Now Official; Calls For New Chemoprevention Program, More Applied Prevention

July 18, 1980